<DOC>
	<DOCNO>NCT01184235</DOCNO>
	<brief_summary>The study examine actigraphic , observational , psychometric associate repeated measurement obtain prior psychopharmacological treatment .</brief_summary>
	<brief_title>Multidimensional Measurement Psychopharmacological Treatment Response</brief_title>
	<detailed_description>Baseline actigraphic measurement , multi-symptom operationally defined observation psychometric data establish repeated measure treatment response . Additional biological biometric measure potential characterize cohort study treatment response collect practical possible .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>Diagnosis : Autism Spectrum Disorder Mood Disorder Attention Deficit Hyperactivity Disorder Unaffected First Degree Relative Study Subject Anticipation pharmacological intervention current pharmacological intervention Inability wear actigraphy watch</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Circadian Disorders</keyword>
	<keyword>Autism Spectrum Disorders</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Executive Functioning</keyword>
	<keyword>Pediatric Mood Disorders</keyword>
</DOC>